AI Medical Compendium Journal:
Frontiers in pharmacology

Showing 21 to 30 of 96 articles

A novel non-invasive murine model for rapidly testing drug activity via inhalation administration against .

Frontiers in pharmacology
The efficacy of many compounds against is often limited when administered via conventional oral or injection routes due to suboptimal pharmacokinetic characteristics. Inhalation-based delivery methods have been investigated to achieve high local the...

Large language models facilitating modern molecular biology and novel drug development.

Frontiers in pharmacology
The latest breakthroughs in information technology and biotechnology have catalyzed a revolutionary shift within the modern healthcare landscape, with notable impacts from artificial intelligence (AI) and deep learning (DL). Particularly noteworthy i...

Inhibition of the polyol pathway by extract: plausible implications for diabetic retinopathy treatment.

Frontiers in pharmacology
INTRODUCTION: Diabetic retinopathy is a significant microvascular disorder and the leading cause of vision impairment in working-age individuals. Hyperglycemia triggers retinal damage through mechanisms such as the polyol pathway and the accumulation...

Clade Ib: a new emerging threat in the Mpox outbreak.

Frontiers in pharmacology
Monkeypox, a zoonotic virus in the , has drawn global attention for its impact on public health. In the current Mpox outbreak, a novel clade, Ib, has emerged as a significant and potentially fatal threat. This review examines the dynamics of MPXV tra...

Comparison of the composition, immunological activity and anti-fatigue effects of different parts in sika deer antler.

Frontiers in pharmacology
BACKGROUND: Sika deer (, 1838) antler is a highly esteemed tonic renowned for its abundant assortment of polypeptides, polysaccharides, amino acids, and minerals, and is recognized for its multifarious pharmacological properties. However, limited res...

Pharmacokinetics, bioavailability, and tissue distribution of MRTX1133 in rats using UHPLC-MS/MS.

Frontiers in pharmacology
INTRODUCTION: MRTX1133 is a selective and reversible small molecule inhibitor of KRAS (G12D), which significantly delays the progression of solid tumors. However, no study on the absorption, distribution, and excretion of MRTX1133.

Catalpol promotes hippocampal neurogenesis and synaptogenesis in rats after multiple cerebral infarctions by mitochondrial regulation: involvement of the Shh signaling pathway.

Frontiers in pharmacology
INTRODUCTION: Ischemic stroke greatly threatens human life and health. Neuro-restoration is considered to be the critical points in reestablishing neurological function and improving the quality of life of patients. Catalpol is the main active ingred...

Investigating the anti-obesity potential of leaf bioactive compounds through machine learning and computational biology methods.

Frontiers in pharmacology
Obesity, a growing global health concern, is linked to severe ailments such as cardiovascular diseases, type 2 diabetes, cancer, and neuropsychiatric disorders. Conventional pharmacological treatments often have significant side effects, highlighting...

Monitoring of the trough concentration of valproic acid in pediatric epilepsy patients: a machine learning-based ensemble model.

Frontiers in pharmacology
AIMS: Few personalized monitoring models for valproic acid (VPA) in pediatric epilepsy patients (PEPs) incorporate machine learning (ML) algorithms. This study aimed to develop an ensemble ML model for VPA monitoring to enhance clinical precision of ...

Proteomic study of the inhibitory effects of tannic acid on MRSA biofilm.

Frontiers in pharmacology
INTRODUCTION: The mechanism of tannic acid (TA) intervention on methicillin-resistant (MRSA, USA 300) biofilm formation was explored using proteomics.